Logo image of CNVS

CINEVERSE CORP (CNVS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CNVS - US1724063086 - Common Stock

2.1 USD
+0.03 (+1.45%)
Last: 1/16/2026, 7:46:53 PM
2.12 USD
+0.02 (+0.95%)
After Hours: 1/16/2026, 7:46:53 PM
Fundamental Rating

2

Overall CNVS gets a fundamental rating of 2 out of 10. We evaluated CNVS against 80 industry peers in the Entertainment industry. CNVS has a bad profitability rating. Also its financial health evaluation is rather negative. CNVS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CNVS had negative earnings in the past year.
  • In the past year CNVS has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CNVS reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: CNVS reported negative operating cash flow in multiple years.
CNVS Yearly Net Income VS EBIT VS OCF VS FCFCNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • CNVS has a Return On Assets (-2.49%) which is comparable to the rest of the industry.
  • CNVS has a Return On Equity of -4.05%. This is comparable to the rest of the industry: CNVS outperforms 53.75% of its industry peers.
  • With a decent Return On Invested Capital value of 4.39%, CNVS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -2.49%
ROE -4.05%
ROIC 4.39%
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
CNVS Yearly ROA, ROE, ROICCNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • In the last couple of years the Profit Margin of CNVS has grown nicely.
  • CNVS has a better Operating Margin (3.07%) than 65.00% of its industry peers.
  • In the last couple of years the Operating Margin of CNVS has grown nicely.
  • CNVS has a Gross Margin of 52.31%. This is comparable to the rest of the industry: CNVS outperforms 58.75% of its industry peers.
  • CNVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.07%
PM (TTM) N/A
GM 52.31%
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
CNVS Yearly Profit, Operating, Gross MarginsCNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

More info and screens

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNVS is destroying value.
  • CNVS has more shares outstanding than it did 1 year ago.
  • CNVS has more shares outstanding than it did 5 years ago.
  • CNVS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CNVS Yearly Shares OutstandingCNVS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CNVS Yearly Total Debt VS Total AssetsCNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • CNVS has an Altman-Z score of -9.14. This is a bad value and indicates that CNVS is not financially healthy and even has some risk of bankruptcy.
  • CNVS has a worse Altman-Z score (-9.14) than 83.75% of its industry peers.
  • A Debt/Equity ratio of 0.17 indicates that CNVS is not too dependend on debt financing.
  • The Debt to Equity ratio of CNVS (0.17) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -9.14
ROIC/WACC0.37
WACC11.76%
CNVS Yearly LT Debt VS Equity VS FCFCNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.95 indicates that CNVS may have some problems paying its short term obligations.
  • The Current ratio of CNVS (0.95) is comparable to the rest of the industry.
  • CNVS has a Quick Ratio of 0.95. This is a bad value and indicates that CNVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CNVS has a Quick ratio (0.95) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
CNVS Yearly Current Assets VS Current LiabilitesCNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 75.44% over the past year.
  • CNVS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.37% yearly.
  • CNVS shows a strong growth in Revenue. In the last year, the Revenue has grown by 77.29%.
  • Measured over the past years, CNVS shows a quite strong growth in Revenue. The Revenue has been growing by 14.75% on average per year.
EPS 1Y (TTM)75.44%
EPS 3Y-23.37%
EPS 5YN/A
EPS Q2Q%-244.44%
Revenue 1Y (TTM)77.29%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%-3%

3.2 Future

  • Based on estimates for the next years, CNVS will show a very negative growth in Earnings Per Share. The EPS will decrease by -10.93% on average per year.
  • Based on estimates for the next years, CNVS will show a small growth in Revenue. The Revenue will grow by 5.29% on average per year.
EPS Next Y-615.67%
EPS Next 2Y-10.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.32%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNVS Yearly Revenue VS EstimatesCNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CNVS Yearly EPS VS EstimatesCNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CNVS. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 29.41, CNVS can be considered very expensive at the moment.
  • 75.00% of the companies in the same industry are more expensive than CNVS, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CNVS to the average of the S&P500 Index (24.26), we can say CNVS is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 29.41
CNVS Price Earnings VS Forward Price EarningsCNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

  • 85.00% of the companies in the same industry are more expensive than CNVS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.64
CNVS Per share dataCNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • CNVS's earnings are expected to decrease with -10.93% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.93%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for CNVS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CINEVERSE CORP

NASDAQ:CNVS (1/16/2026, 7:46:53 PM)

After market: 2.12 +0.02 (+0.95%)

2.1

+0.03 (+1.45%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-14
Earnings (Next)02-11
Inst Owners20.27%
Inst Owner Change0%
Ins Owners11.19%
Ins Owner Change1.61%
Market Cap40.22M
Revenue(TTM)79.79M
Net Income(TTM)-1.54M
Analysts82.5
Price Target7.65 (264.29%)
Short Float %2.33%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.06%
Min EPS beat(2)-157.35%
Max EPS beat(2)-78.78%
EPS beat(4)2
Avg EPS beat(4)-18.64%
Min EPS beat(4)-157.35%
Max EPS beat(4)152.29%
EPS beat(8)4
Avg EPS beat(8)-7.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.44%
Min Revenue beat(2)-4.32%
Max Revenue beat(2)7.19%
Revenue beat(4)3
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-4.32%
Max Revenue beat(4)9.79%
Revenue beat(8)4
Avg Revenue beat(8)1.12%
Revenue beat(12)5
Avg Revenue beat(12)1.99%
Revenue beat(16)9
Avg Revenue beat(16)7.11%
PT rev (1m)0%
PT rev (3m)-11.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-133.33%
EPS NY rev (1m)-33.82%
EPS NY rev (3m)-810%
Revenue NQ rev (1m)-7.58%
Revenue NQ rev (3m)-14.72%
Revenue NY rev (1m)-3.25%
Revenue NY rev (3m)-15.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.41
P/S 0.5
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 3.13
EV/EBITDA 5.64
EPS(TTM)-0.14
EYN/A
EPS(NY)0.07
Fwd EY3.4%
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.17
BVpS1.99
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -4.05%
ROCE 6.55%
ROIC 4.39%
ROICexc 4.64%
ROICexgc 11.72%
OM 3.07%
PM (TTM) N/A
GM 52.31%
FCFM N/A
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y117.54%
ROICexc growth 5YN/A
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
F-Score3
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 1
Cap/Depr 24.09%
Cap/Sales 1.26%
Interest Coverage 2.78
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z -9.14
F-Score3
WACC11.76%
ROIC/WACC0.37
Cap/Depr(3y)30.78%
Cap/Depr(5y)28.81%
Cap/Sales(3y)1.85%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.44%
EPS 3Y-23.37%
EPS 5YN/A
EPS Q2Q%-244.44%
EPS Next Y-615.67%
EPS Next 2Y-10.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)77.29%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%-3%
Revenue Next Year-15.32%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y177%
EBIT growth 3Y93.13%
EBIT growth 5YN/A
EBIT Next Year-112.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.53%
FCF growth 3Y56.46%
FCF growth 5Y20.06%
OCF growth 1Y78.1%
OCF growth 3Y52.8%
OCF growth 5Y17.54%

CINEVERSE CORP / CNVS FAQ

What is the fundamental rating for CNVS stock?

ChartMill assigns a fundamental rating of 2 / 10 to CNVS.


What is the valuation status of CINEVERSE CORP (CNVS) stock?

ChartMill assigns a valuation rating of 1 / 10 to CINEVERSE CORP (CNVS). This can be considered as Overvalued.


What is the profitability of CNVS stock?

CINEVERSE CORP (CNVS) has a profitability rating of 3 / 10.


What is the financial health of CINEVERSE CORP (CNVS) stock?

The financial health rating of CINEVERSE CORP (CNVS) is 2 / 10.